SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-001932
Filing Date
2022-02-24
Accepted
2022-02-24 16:16:09
Documents
98
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K knsa-20211231x10k.htm   iXBRL 10-K 3318951
2 EX-10.33 knsa-20211231xex10d33.htm EX-10.33 186325
3 EX-10.34 knsa-20211231xex10d34.htm EX-10.34 480133
4 EX-10.35 knsa-20211231xex10d35.htm EX-10.35 22523
5 EX-10.36 knsa-20211231xex10d36.htm EX-10.36 319446
6 EX-10.37 knsa-20211231xex10d37.htm EX-10.37 180566
7 EX-10.38 knsa-20211231xex10d38.htm EX-10.38 720093
8 EX-23.1 knsa-20211231xex23d1.htm EX-23.1 1965
9 EX-31.1 knsa-20211231xex31d1.htm EX-31.1 14184
10 EX-31.2 knsa-20211231xex31d2.htm EX-31.2 14128
11 EX-32.1 knsa-20211231xex32d1.htm EX-32.1 7694
12 EX-32.2 knsa-20211231xex32d2.htm EX-32.2 7608
13 GRAPHIC knsa-20211231x10k006.jpg GRAPHIC 34923
14 GRAPHIC knsa-20211231x10k008.jpg GRAPHIC 47620
15 GRAPHIC knsa-20211231xex10d35001.jpg GRAPHIC 7481
16 GRAPHIC knsa-20211231xex10d36001.jpg GRAPHIC 651
17 GRAPHIC knsa-20211231xex10d37001.jpg GRAPHIC 6800
  Complete submission text file 0001558370-22-001932.txt   13827432

Data Files

Seq Description Document Type Size
18 EX-101.SCH knsa-20211231.xsd EX-101.SCH 71596
19 EX-101.CAL knsa-20211231_cal.xml EX-101.CAL 77210
20 EX-101.DEF knsa-20211231_def.xml EX-101.DEF 324075
21 EX-101.LAB knsa-20211231_lab.xml EX-101.LAB 657324
22 EX-101.PRE knsa-20211231_pre.xml EX-101.PRE 510130
92 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20211231x10k_htm.xml XML 1919960
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38492 | Film No.: 22671174
SIC: 2834 Pharmaceutical Preparations